Prof F Martin
Chief Executive officer and Director
 R&D
Lonza Group Ltd
Belgium
Biography
Dr. Keith F. Martin, Ph.D., M.R.PharmS serves as Chief Executive Officer of Apitope Technology (Bristol) Limited. Dr. Martin has 20+ years pharmaceutical R&D and business start-up and development experience. Dr. Martin founded and served as President of KetoCytonyx, Inc. Dr. Martin served as Global Director of Life Sciences (BTG). Dr. Martin also served as Section Head at BASF Pharma with responsibility for neuroscience research, epilepsy drug discovery and product development support. Dr. Martin was key member of pre-clinical team that developed and registered Meridia (sibutramine) in USA. Dr. Martin serves as Director of Apitope Technology (Bristol) Limited. Dr. Martin is trained in pharmacy and neuropharmacology.
Research Interest
neuropharmacology
